Mechanisms Underlying Improvement in Right Ventricular (RV) Function in a Rat Model of Pulmonary Arterial Hypertension (PAH) and RV Dysfunction

被引：0
|
作者：
Middleton, R. [1 ]
Soetkamp, D. [2 ]
Fournier, M. [2 ]
Liu, W. [2 ]
Voelkel, N. F.
van Eyk, J. E. [2 ]
Marban, E. [2 ]
Lewis, M. I. [3 ]
机构：
[1] Univ Calif San Diego, Bioengn, La Jolla, CA 92093 USA
[2] Cedars Sinai Med Ctr, Heart Inst, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Med, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3694
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Right Ventricular Function in Pulmonary Hypertension: Prospective 3d Echocardiographic Analysis of RV Remodeling and Contracility
    Lamia, B.
    Lambert, T.
    Azzi, M.
    Bidar, F.
    Picard, A.
    Bonnet, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [32] Inhaled nitric oxide is a negative right ventricular (RV) inotrope in primary pulmonary hypertension
    Counihan, PJ
    Gorcsan, J
    Firestone, L
    Mandarino, WA
    Katz, WE
    Feldman, MD
    Murali, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7161 - 7161
  • [33] Regional right ventricular myocardial strain by echocardiographic speckle trucking distinguishes clinical and hemodynamic RV dysfunction in pulmonary hypertension
    Reali, Manuela
    Rajagopalan, Navin
    Lopez-Candales, Angel
    Cordero, Kevin E.
    Suffoletto, Mattew
    Shroff, Sanjeev G.
    Pinsky, Michael R.
    Goresan, John
    Mathier, Michael A.
    Simon, Marc A.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S17 - S17
  • [34] Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard N.
    Delcroix, Marion
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck -Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Rubin, Lewis J.
    Sastry, B. K. S.
    Simonneau, Gerald
    Souza, Rogerio
    Torbicki, Adam
    Galie, Nazzareno
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [35] Macitentan reduces the risk of morbidity mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard N.
    Delcroix, Marion
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck -Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Rubin, Lewis J.
    Sastry, B. K. S.
    Simonneau, Gerald
    Souza, Rogerio
    Torbicki, Adam
    Galie, Nazzareno
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [36] Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Caputo, Annalisa
    Papa, Silvia
    Manzi, Giovanna
    Laviola, Domenico
    Recchioni, Tommaso
    Severino, Paolo
    Lavalle, Carlo
    Maestrini, Viviana
    Mancone, Massimo
    Badagliacca, Roberto
    Vizza, Carmine Dario
    CURRENT HEART FAILURE REPORTS, 2023, 20 (04) : 263 - 270
  • [37] Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Prisco, Sasha Z.
    Thenappan, Thenappan
    Prins, Kurt W.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2020, 5 (12): : 1244 - 1260
  • [38] Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Annalisa Caputo
    Silvia Papa
    Giovanna Manzi
    Domenico Laviola
    Tommaso Recchioni
    Paolo Severino
    Carlo Lavalle
    Viviana Maestrini
    Massimo Mancone
    Roberto Badagliacca
    Carmine Dario Vizza
    Current Heart Failure Reports, 2023, 20 : 263 - 270
  • [39] Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Thenappan, Thenappan
    Weir, E. Kenneth
    Prins, Kurt W.
    Pritzker, Marc R.
    Archer, Stephen L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (14):
  • [40] Nimura lecture: why are you evaluating RV function in patients with pulmonary arterial hypertension?
    Katsu Takenaka
    Journal of Echocardiography, 2019, 17 : 1 - 4
12345